Analytical Data
-
基因名
LCP1
- Application
-
别名
LCP1；C14orf92；KIAA0737；TOX high mobility group box family member 4
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P13796
-
表达区间
2-627aa
-
氨基酸序列
ARGSVSDEEMMELREAFAKVDTDGNGYISFNELNDLFKAACLPLPGYRVREITENLMATGDLDQDGRISFDEFIKIFHGLKSTDVAKTFRKAINKKEGICAIGGTSEQSSVGTQHSYSEEEKYAFVNWINKALENDPDCRHVIPMNPNTNDLFNAVGDGIVLCKMINLSVPDTIDERTINKKKLTPFTIQENLNLALNSASAIGCHVVNIGAEDLKEGKPYLVLGLLWQVIKIGLFADIELSRNEALIALLREGESLEDLMKLSPEELLLRWANYHLENAGCNKIGNFSTDIKDSKAYYHLLEQVAPKGDEEGVPAVVIDMSGLREKDDIQRAECMLQQAERLGCRQFVTATDVVRGNPKLNLAFIANLFNRYPALHKPENQDIDWGALEGETREERTFRNWMNSLGVNPRVNHLYSDLSDALVIFQLYEKIKVPVDWNRVNKPPYPKLGGNMKKLENCNYAVELGKNQAKFSLVGIGGQDLNEGNRTLTLALIWQLMRRYTLNILEEIGGGQKVNDDIIVNWVNETLREAKKSSSISSFKDPKISTSLPVLDLIDAIQPGSINYDLLKTENLNDDEKLNNAKYAISMARKIGARVYALPEDLVEVNPKMVMTVFACLMGKGMKRV
-
分子量
72.2kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LCP1 (Lymphocyte Cytosolic Protein 1) is a member of the LCP protein family, playing a crucial role in T cell signaling and development. Research into LCP1 recombinant proteins has gained momentum due to its significance in immune responses and potential implications in various diseases, including autoimmune disorders and cancers. LCP1 is known to participate in actin cytoskeleton organization and cell motility, which are vital for effective T cell function and response to pathogens. Additionally, LCP1's involvement in lymphocyte proliferation and differentiation underscores its potential as a target for therapeutic interventions. Studies employing recombinant LCP1 proteins have provided valuable insights into the mechanisms of immune regulation and the intricate network of signaling pathways that govern T cell activities. By utilizing recombinant DNA technology, researchers can produce LCP1 in vitro, facilitating detailed functional analyses and structural studies. This not only enhances our understanding of LCP1’s biological functions but also opens avenues for exploring its utility in vaccine development and immunotherapy strategies, particularly in the context of enhancing T cell responses against tumors or infectious agents. Therefore, LCP1 recombinant protein research is pivotal in elucidating immune mechanisms and advancing clinical applications aimed at improving human health.
